Novartis Sets $39 Billion Path To Purchasing Eye Care Market Leader Alcon

Diversified drug, diagnostics and ophthalmic device giant Novartis will acquire a 25% stake in eye care market leader Alcon as a first step toward potentially gaining majority ownership of the company by 2011, the firms announced April 7